Your medical briefing

Stay current.
Stay focused.

Research, guidelines, and safety alerts for your specialty.

Surgery

Recent updates in Surgery from the last 30 days.

AllAll updates Research Guidelines Safety alerts

The PACTOL randomized trial compared ultrasound-guided transvaginal drainage with laparoscopy for evacuation of tubo-ovarian abscess in 208 patients across 19 French hospitals. The trial reported that noninferiority of transvaginal drainage was not established, with reintervention needed more often in the transvaginal drainage group (13.0% vs 3.3%), though hospitalization was shorter and pain scores decreased more quickly with transvaginal drainage. The trial reported no differences between groups in persistence of the collection, reintroduction of antibiotic therapy, or rates of grade II or higher surgical complications.

Stay current.
Stay focused.

Surgery

Trial finds transvaginal drainage not proven noninferior to laparoscopy for abscess

WSES issues new evidence-based guidelines for colorectal trauma management

Series highlights underdiagnosis and poor prognosis of peripheral arterial disease

Review outlines current medical and surgical management approaches for PAD

Review outlines progress and evidence base for cancer vaccines

Medicare Advantage linked to lower kidney transplant and wait-listing rates

5-Year Surveillance Colonoscopy Noninferior to 3-Year After Polyp Removal

Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporat

Short antibiotic course noninferior after orthopedic infection surgery

Robotic cholecystectomy tied to fewer complications but higher cost

Six hospital resources linked to lower mortality after pancreas surgery

Review outlines diagnosis and shunt outcomes in idiopathic NPH

Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath

Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u

Class II recall: Baxter Healthcare Corporation: Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Cont

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Sin

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in G

Class II recall: Baxter Healthcare Corporation: Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/m

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bot

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bot

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count b

Class II recall: Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and

Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Onl

Stay current. Stay focused.

Stay current.
Stay focused.